📰 Andreaf Wainer News
Page 40 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
January 10, 2024
Whittier Trust Co. increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.4% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 373,375 shares of the healthcare product maker’s stock after purchasing an additional 5,058 shares during the period. Whittier Trust Co.’s holdings […]
January 10, 2024
Abbott Laboratories (NYSE:ABT – Get Free Report) announced a quarterly dividend on Friday, December 15th, RTT News reports. Investors of record on Friday, January 12th will be given a dividend of 0.55 per share by the healthcare product maker on Thursday, February 15th. This represents a $2.20 annualized dividend and a yield of 1.95%. The […]
January 10, 2024
Capital Advisors Ltd. LLC lessened its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,887 shares of the healthcare product maker’s stock after selling 187 shares during the quarter. Capital Advisors Ltd. LLC’s holdings […]
January 10, 2024
Hennion & Walsh Asset Management Inc. raised its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 14.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 41,038 shares of the healthcare product maker’s stock after buying an additional 5,061 shares […]
January 10, 2024
Brady Family Wealth LLC lifted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,734 shares of the healthcare product maker’s stock after purchasing an additional 750 shares during […]
January 9, 2024
Detalus Advisors LLC lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 5.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 15,642 shares of the healthcare product maker’s stock after selling 980 shares during the quarter. Detalus Advisors LLC’s […]
January 9, 2024
Conning Inc. lifted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 332,655 shares of the healthcare product maker’s stock after purchasing an additional 8,789 shares during the quarter. Conning Inc.’s holdings […]
January 9, 2024
Keel Point LLC reduced its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 8.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,099 shares of the healthcare product maker’s stock after selling 585 shares during […]
January 9, 2024
Oregon Public Employees Retirement Fund lowered its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 134,159 shares of the healthcare product maker’s stock after selling 1,200 shares during the quarter. Oregon […]
January 9, 2024
BSW Wealth Partners cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,627 shares of the healthcare product maker’s stock after selling 327 shares during the period. BSW […]